Want this question answered?
After - as in POSTtraumatic stress disorder
The prevalence of schizotypal personality disorder is estimated to range from 0.6% to 5.1%, with a median rate of about 3% of the nonclinical population. In a clinical sample of psychiatric patients, the prevalence ranged from 2.0% to 64%, with a median prevalence of 17.5%. This wide variation in prevalence rates may reflect the controversy surrounding the classification of schizotypal disorder as a separate personality disorder, instead of a component of schizophrenia.
PDS is not a brain disorder, but an acronym for a test to screen for Posttramatic Stress Disorder, which is considered an anxiety disorder (so yes, it is a brain disorder) PDS stands for "Posttraumatic Stress Diagnostic Scale." At least, if you're referring to the same acronym I think you are.
Incidence and prevalence of DIM are unknown. Myopathy caused by corticosteroids is the most common disorder, and it is more common in women.
1 in 100 of the population have autistic spectrum disorder. 0.2% are female, and 1.8% are male.
PTSD/Posttraumatic stress disorder
PTSD/Posttraumatic stress disorder
The prevalence rate of bipolar disorder appears to be equal among men and women
PTSD has specific chronological requirements and symptom markers that must be satisfied in order to diagnose
Yes, bipolar disorder affects men and women in about equal numbers but it manifests in different ways between the sexes.
Estimates as to the worldwide prevalence of bipolar disorder are mixed. It is thought there is a lifelong prevalence rate of about 0.3-1.5% internationally for bipolar disorder. According to Merikangas et al, using World Health Organization information, it's about 0.6% for bipolar I, 0.4% for bipolar II and about 1.4% subthreashold bipolar disorder.Comparatively, in the United States, the lifelong prevalence for bipolar disorder is thought to be from 1-1.6%. This is broken down into 1% for bipolar I, 1.1% for bipolar II and about 2.4-4.7% subthreashold bipolar disorder. It is not known why bipolar disorder (especially subthreashold) appears more frequently in the United States.References: Medscape Reference - http://emedicine.medscape.com/article/286342-overview#showallEstimates as to the worldwide prevalence of bipolar disorder are mixed. It is thought there is a lifelong prevalence rate of about 0.3-1.5% internationally for bipolar disorder. According to Merikangas et al, using World Health Organization information, it's about 0.6% for bipolar I, 0.4% for bipolar II and about 1.4% subthreashold bipolar disorder.Comparatively, in the United States, the lifelong prevalence for bipolar disorder is thought to be from 1-1.6%. This is broken down into 1% for bipolar I, 1.1% for bipolar II and about 2.4-4.7% subthreashold bipolar disorder. It is not known why bipolar disorder (especially subthreashold) appears more frequently in the United States.References: Medscape Reference - http://emedicine.medscape.com/article/286342-overview#showall
From the manufacturer (Pfizer): Zoloft is FDA approved to treat depression, certain types of social anxiety conditions, posttraumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD) in adults over age 18. It is also approved for OCD in children and adolescents age 6-17 years.